The Dow Jones powered ahead Tuesday despite some less-than-splendid earnings from Verizon and Johnson & Johnson. Also, Google impressed after hours. More
-
-
Sponsored By:
-
Sponsored By:
ARNA
Apple Keeps Biting the Nasdaq — Tuesday’s IP Market Recap
Apple stock finished below $500 for the first time in nearly a year, weighing down the Nasdaq on a day otherwise bolstered by hot retail stocks. More
Stocks Dip on Pre-Earnings Jitters — Tuesday’s IP Market Recap
Investors leery of a potentially weak fourth-quarter earnings season bid stocks down lower Tuesday, though Alcoa "officially" started things off right after the bell. More
4 Attractive Biopharma Stocks of All Sizes
Biopharma is a high-growth niche in a defensive sector, but you need to balance risk with reward. Here are four hot biopharma stocks of different sizes. More
My Brilliant Biotech Move for 2012
An overly helter-skelter year in the world of biotech stocks has been a stark reminder of a basic lesson that isn't followed enough: Keep it simple. More
Biotech Movers: Sequenom Soars on Blood Test Success
SONM sees significant gains despite a sub-par earnings report. Plus: Why Array and Vivus took big falls. More
Sandy Departs, Markets Open — Wednesday’s IP Market Recap
Markets reopened on Wednesday after their historic two-day close due to Hurricane Sandy. Stocks had mixed results on slow trading volume. More
